<i>Candida albicans</i> targets that potentially synergize with fluconazole

Fluconazole has characteristics that make it widely used in the clinical treatment of <i>C. albicans</i> infections. However, fluconazole has only a fungistatic activity in <i>C. albicans,</i> therefore, in the long-term treatment of <i>C. albicans</i> infection with fluconazole, <i>C. albicans</i> has the potential to acquire fluconazole resistance. A promising approach to increase fluconazole’s efficacy is identifying potential targets of drugs that can enhance the antifungal effect of fluconazole, or even make the drug fungicidal. In this review, we systematically provide a global overview of potential targets of drugs synergistic with fluconazole in <i>C. albicans</i>, identify new avenues for research on fluconazole potentiation, and highlight the promise of combinatorial strategies with fluconazole in combatting <i>C. albicans</i> infections.